Cancer Therapeutics Market

Global Cancer Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centre), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 22 2024 with the latest and most recent market numbers

Cancer Therapeutics Market Insights

The global cancer therapeutics market will grow from USD 140.22 billion in 2021 to reach USD 230.12 billion in 2026, with a CAGR of 8.52% from 2021 to 2026. Cancer therapies are described as techniques that deliver target-specific drugs to cancer cells to prevent or stop the growth of tumors that cause cell death. It typically consists of radiation, chemotherapy, and surgery. However, there are numerous methods of cancer treatment, and the application of therapy is determined by the type and stage of cancer. The factors supporting the cancer therapeutics market growth are the rising incidence of cancer across the globe, rising demand for personalized medicines, growing patient assistance programs (PAPS), and growing government initiatives for cancer awareness.

Cancer is a disease caused by uncontrolled and irregular cell proliferation that invades or spreads to other parts of the body. Cancer is the second biggest cause of mortality rate worldwide, and as per the WHO, there were more than 10 million deaths recorded in 2020. As a result of this, the cancer diagnostics market value has gained high importance in order to avoid complications in the later stage of cancer. The rising geriatric patient population is also another major factor affecting the growth of the cancer therapeutics market growth positively.

Furthermore, the cancer therapeutics market trends will be growing rapidly owing to factors such as the increasing number of cancer cases, increasing geriatric patient pool especially in developing regions, and rising number of acquisitions & mergers to facilitate drug development. Some of the most prominent selling drugs for cancer treatment are Revlimid, Imbruvica, Xtandi, Opdivo, and Avastin, among others.

The COVID-19 pandemic had a global impact on healthcare systems and has had a considerable influence on the cancer therapeutic market size. According to an article namely the Cancer Connect 2020, doctors from Dana Farber Cancer Institute discovered that during the COVID-19 pandemic, a 46% decline in diagnoses of the six most frequent cancer types - gastric, breast, pancreatic, colorectal, lung, and oesophageal cancers was witnessed. The OPD visits, cancer drug prescription, and delayed surgeries have helped decline the demand for cancer therapeutic drugs. This shows that the pandemic has affected the market drastically.

global cancer therapeutics market

Cancer Therapeutics Market: By Therapy

The cancer therapeutics market is categorized into chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. The targeted therapy segment is analyzed to be the fastest-growing segment in the market from 2021 to 2026. Targeted therapy is a rapidly expanding field of cancer research.

The immunotherapy segment is expected to hold the largest shareholder of the market during the forecast period owing to its cancer-specificity while avoiding toxicity in non-target cells. Recent advancements in biological therapies have expanded the choice of therapeutic targets for cancer treatment by identifying tumor cell-specific genes. Immunotherapies/biologics are developing as possible medicines for finding a permanent cure for many cancer types among numerous cancer therapeutics.

Cancer Therapeutics Market: By Application

Blood cancer, lung cancer, colorectal cancer, and prostate cancer, among others, are the major segments of the cancer therapeutics market. The lung cancer segment will be the largest shareholder of the market owing to factors such as the increasing incidence of lung cancer because of the rising smoking population and favorable government policies for lung cancer therapeutics. Moreover, the increasing popularity of the treatment procedure through digital advertisements, propelling the cancer therapeutics market share during the forecast period.

The prostate cancer segment will be the fastest-growing segment with the highest CAGR value from 2021 to 2026. The factors attributed to the cancer therapeutics market growth are the rising cases of cardiovascular diseases and prostate cancer.

Cancer Therapeutics Market: By End-User

Hospitals, specialty clinics, cancer, and radiation therapy center are the end-users of the market. Cancer and radiation therapy center is expected to hold the largest market shareholder owing to the increasingly large number of cancer treatments being performed in such centers. According to the National Health Expenses, hospital’s cancer care treatment accounts for more than 32 percent of total healthcare expenditures.

asia pacific cancer therapeutics market

Cancer Therapeutics Market: By Region

As per the geographical analysis, the market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico) will have a dominant share in the market during the forecast period. The high share of this region is mainly due to the presence of key players in the US market, increasing healthcare expenditure, increasing investments in R&D activities to launch minimally invasive cancer diagnostics tools, and increasing acceptance of cancer therapeutics among geriatric patient population.

However, on the contrary, the Asia Pacific region will grow with the highest CAGR rate in the market. Rising research & innovation activities, growing disposable income, and increasing awareness of cancer therapeutics will impact the cancer therapeutic market trends positively. Furthermore, the growing medical tourism industry in countries such as India, China, and Malaysia is likely to drive up demand for oncological screening. Cancer treatments are quickly expanding in India and helping the cancer therapeutics market size increase exponentially.

Cancer Therapeutics Market Share and Competitor Analysis

F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Pfizer, Inc., Novartis AG, Merck KGaA, Bayer AG, and Takeda Pharmaceutical Company Limited, among others are some of the key players in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

In January 2020, Merck KGaA successfully acquired ArQule Inc. Merck KGaA is recognized as a biopharmaceutical firm that focuses on kinase inhibitor development and discovery for the treatment of patients suffering from cancer.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Cancer Therapeutics Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 End-User Overview

2.1.3 Therapy Overview

2.1.4 Application Overview

2.1.5 Regional Overview

Chapter 3 Global Cancer Therapeutics Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rising demand for personalized medicines

3.3.1.2 Growing incidence of cancer

3.3.2 Industry Challenges

3.3.2.1 High cost of cancer therapies

3.4 Prospective Growth Scenario

3.4.1 End-User Growth Scenario

3.4.2 Therapy Growth Scenario

3.4.3 Application Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Global Cancer Therapeutics Market, By End-User

4.1 End-User Outlook

4.2 Hospitals

4.2.1 Market Size, By Region, 2020-2026 (USD Billion)

4.3 Specialty Clinics

4.3.1 Market Size, By Region, 2020-2026 (USD Billion)

4.4 Cancer and Radiation Therapy Centre

4.4.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5 Global Cancer Therapeutics Market, By Therapy

5.1 Therapy Outlook

5.2 Chemotherapy

5.2.1 Market Size, By Region, 2020-2026 (USD Billion)

5.3 Targeted Therapy

5.3.1 Market Size, By Region, 2020-2026 (USD Billion)

5.4 Immunotherapy

5.4.1 Market Size, By Region, 2020-2026 (USD Billion)

5.5 Hormonal Therapy

5.5.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6 Cancer Therapeutics Market, By Application

6.1 Application Outlook

6.2 Blood Cancer

6.2.1 Market Size, By Region, 2020-2026 (USD Billion)

6.3 Lung Cancer

6.3.1 Market Size, By Region, 2020-2026 (USD Billion)

6.4 Colorectal Cancer

6.4.1 Market Size, By Region, 2020-2026 (USD Billion)

6.5 Prostrate Cancer

6.5.1 Market Size, By Region, 2020-2026 (USD Billion)

6.6 Skin Cancer

6.6.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 7 Cancer Therapeutics Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market Size, By Country 2020-2026 (USD Billion)

7.2.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.3 Market Size, By Therapy, 2020-2026 (USD Billion)

7.2.4 Market Size, By Application, 2020-2026 (USD Billion)

7.2.5 U.S.

7.2.5.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.5.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.2.5.3 Market Size, By Application, 2020-2026 (USD Billion)

7.2.6 Canada

7.2.6.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.2.6.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.2.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3 Europe

7.3.1 Market Size, By Country 2020-2026 (USD Billion)

7.3.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.3 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.4 Market Size, By Application, 2020-2026 (USD Billion)

7.3.5 Germany

7.3.5.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.5.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.5.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.6 UK

7.3.6.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.6.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.7 France

7.3.7.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.7.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.8 Italy

7.3.8.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.8.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.8.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.9 Spain

7.3.9.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.9.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.9.3 Market Size, By Application, 2020-2026 (USD Billion)

7.3.10 Russia

7.3.10.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.3.10.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.3.10.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4 Asia Pacific

7.4.1 Market Size, By Country,2020-2026 (USD Billion)

7.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.3 Market Size, By Therapy, 2020-2026 (USD Billion)

7.4.4 Market Size, By Application, 2020-2026 (USD Billion)

7.4.5 China

7.4.5.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.5.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.4.5.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.6 India

7.4.6.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.6.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.4.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.7 Japan

7.4.7.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.7.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.4.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.8 Australia

7.4.8.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.8.2 Market size, By Therapy, 2020-2026 (USD Billion)

7.4.8.3 Market Size, By Application, 2020-2026 (USD Billion)

7.4.9 South Korea

7.4.9.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.4.9.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.4.9.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6.5 Latin America

7.5.1 Market Size, By Country 2020-2026 (USD Billion)

7.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.3 Market Size, By Therapy, 2020-2026 (USD Billion)

7.5.4 Market Size, By Application, 2020-2026 (USD Billion)

7.5.5 Brazil

7.5.5.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.5.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.5.5.3 Market Size, By Application, 2020-2026 (USD Billion)

7.5.6 Mexico

7.5.6.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.6.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.5.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.5.7 Argentina

7.5.7.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.5.7.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.5.7.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6 MEA

7.6.1 Market Size, By Country 2020-2026 (USD Billion)

7.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.3 Market Size, By Therapy, 2020-2026 (USD Billion)

7.6.4 Market Size, By Application, 2020-2026 (USD Billion)

7.6.5 Saudi Arabia

7.6.5.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.5.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.6.5.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6.6 UAE

7.6.6.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.6.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.6.6.3 Market Size, By Application, 2020-2026 (USD Billion)

7.6.7 South Africa

7.6.7.1 Market Size, By End-User, 2020-2026 (USD Billion)

7.6.7.2 Market Size, By Therapy, 2020-2026 (USD Billion)

7.6.7.3 Market Size, By Application, 2020-2026 (USD Billion)

Chapter 8 Company Landscape

8.1 Competitive Analysis, 2020

8.2 F. Hoffmann-La Roche AG

8.2.1 Company Overview

8.2.2 Financial Analysis

8.2.3 Strategic Positioning

8.2.4 InfoGraphic Analysis

8.3 Bristol-Myers Squibb Company

8.3.1 Company Overview

8.3.2 Financial Analysis

8.3.3 Strategic Positioning

8.3.4 InfoGraphic Analysis

8.4 AbbVie, Inc

8.4.1 Company Overview

8.4.2 Financial Analysis

8.4.3 Strategic Positioning

8.4.4 InfoGraphic Analysis

8.5 Johnson & Johnson

8.5.1 Company Overview

8.5.2 Financial Analysis

8.5.3 Strategic Positioning

8.5.4 InfoGraphic Analysis

8.6 Celgene Corporation

8.6.1 Company Overview

8.6.2 Financial Analysis

8.6.3 Strategic Positioning

8.6.4 InfoGraphic Analysis

8.7 Astellas Pharma, Inc.

8.7.1 Company Overview

8.7.2 Financial Analysis

8.7.3 Strategic Positioning

8.7.4 InfoGraphic Analysis

8.8 Pfizer, Inc.

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 InfoGraphic Analysis

8.9 Novartis AG

8.9.1 Company Overview

8.9.2 Financial Analysis

8.9.3 Strategic Positioning

8.9.4 InfoGraphic Analysis

8.10 Bayer AG

8.10.1 Company Overview

8.10.2 Financial Analysis

8.10.3 Strategic Positioning

8.10.4 InfoGraphic Analysis

8.11 Merck KGaA

8.11.1 Company Overview

8.11.2 Financial Analysis

8.11.3 Strategic Positioning

8.11.4 InfoGraphic Analysis

8.12 Other Companies

8.12.1 Company Overview

8.12.2 Financial Analysis

8.12.3 Strategic Positioning

8.12.4 InfoGraphic Analysis

The Global Cancer Therapeutics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cancer Therapeutics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global cancer therapeutics market?

The global cancer therapeutics market size is projected to grow from USD 140.22 billion in 2021 to USD 230.12 billion by 2026, at a CAGR of 8.52% during the forecast period.

Who are the major vendors in the cancer therapeutics market?

Key and innovative vendors in the cancer therapeutics market include F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Pfizer, Inc., Novartis AG, Merck KGaA, Bayer AG, and Takeda Pharmaceutical Company Limited.

Which region has the highest market share in the cancer therapeutics market?

North America is estimated to hold the highest market share in the cancer therapeutics market.

What is the Covid-19 impact on future cancer therapeutics manufacturers?

Globally, Covid-19 impact on the future cancer therapeutics market will be quite significant for the manufacturers. North America would be leading because of the growing proportion of key players in the US market and increasing healthcare expenditure. Subsequently, the Asia Pacific market will be growing the fastest because of the growing disposable income and increasing awareness of cancer therapeutic.

What are the major drivers in the cancer therapeutics market?

The major driving factors for the cancer therapeutics market include the increasing incidence of cancer; the growing geriatric patient population; the rising number of acquisitions & mergers to facilitate drug development.